Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry()

The identification of amyloid-binding compounds is a crucial step in the development of imaging probes and therapeutics for the detection and cure of Alzheimer's disease. Unfortunately, the process typically lags during the translation from in vitro to in vivo studies due to the impenetrable na...

Descripción completa

Detalles Bibliográficos
Autores principales: McClure, Richard A., Chumbley, Chad W., Reyzer, Michelle L., Wilson, Kevin, Caprioli, Richard M., Gore, John C., Pham, Wellington
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778261/
https://www.ncbi.nlm.nih.gov/pubmed/24179813
http://dx.doi.org/10.1016/j.nicl.2013.04.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778261/
https://www.ncbi.nlm.nih.gov/pubmed/24179813
http://dx.doi.org/10.1016/j.nicl.2013.04.015

Ejemplares similares